P Zis1, P Martinez-Martin2, A Sauerbier1,3, A Rizos1, J C Sharma4, P F Worth5, R Sophia6, M Silverdale7, K Ray Chaudhuri1,3. 1. National Parkinson Foundation International Centre of Excellence, King's College Hospital NHS Foundation Trust, London, UK. 2. National Centre of Epidemiology and Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain. 3. King's College London, London. 4. United Lincolnshire Hospitals NHS Trust, Lincoln, UK. 5. Addenbrooke's Hospital, Cambridge, UK. 6. Yeovil Hospital NHS Foundation Trust, Somerset, UK. 7. Salford Royal NHS Foundation Trust, Manchester, UK.
Abstract
BACKGROUND AND PURPOSE: Non-motor symptoms (NMSs) occurring at an early stage of Parkinson's disease (PD) may impair quality of life more than motor symptoms. This study aimed to evaluate the severity of overall NMS profile and burden of NMSs in early PD patients, treated (time since confirmed diagnosis of 5 years or less) or drug naive (DN). METHODS: Cross-sectional data from an ongoing multicentre study (16 sites) were obtained and specifically an NMS data set from validated scales was analysed in treated and DN PD patients. RESULTS: A full data set was available in 234 unique early PD patients. Of them, there were 170 treated (63.5% males, mean age 68.2 years) and 64DN patients (64.1% males, mean age 66.5 years). Compared to DN patients the time since confirmed diagnosis was significantly longer in treated PD patients (1.9 years vs. 3.7 years, P < 0.001). Fatigue (57.7%), urinary urgency (57.1%), nocturia (55.3%), memory difficulties (51.2%) and urinary frequency (48.8%) were the most prevalent NMSs amongst treated PD, whereas DN PD reported most frequently sadness (57.8%), fatigue (57.8%), lightheadedness (53.1%), memory difficulties (48.4%) and urinary urgency (46.9%). CONCLUSIONS: Our results suggest that NMSs are dominant in the untreated and early phase of PD causing a considerable burden. This warrants investigation of the issue of NMS subtyping within PD.
BACKGROUND AND PURPOSE: Non-motor symptoms (NMSs) occurring at an early stage of Parkinson's disease (PD) may impair quality of life more than motor symptoms. This study aimed to evaluate the severity of overall NMS profile and burden of NMSs in early PDpatients, treated (time since confirmed diagnosis of 5 years or less) or drug naive (DN). METHODS: Cross-sectional data from an ongoing multicentre study (16 sites) were obtained and specifically an NMS data set from validated scales was analysed in treated and DN PDpatients. RESULTS: A full data set was available in 234 unique early PDpatients. Of them, there were 170 treated (63.5% males, mean age 68.2 years) and 64DN patients (64.1% males, mean age 66.5 years). Compared to DN patients the time since confirmed diagnosis was significantly longer in treated PDpatients (1.9 years vs. 3.7 years, P < 0.001). Fatigue (57.7%), urinary urgency (57.1%), nocturia (55.3%), memory difficulties (51.2%) and urinary frequency (48.8%) were the most prevalent NMSs amongst treated PD, whereas DN PD reported most frequently sadness (57.8%), fatigue (57.8%), lightheadedness (53.1%), memory difficulties (48.4%) and urinary urgency (46.9%). CONCLUSIONS: Our results suggest that NMSs are dominant in the untreated and early phase of PD causing a considerable burden. This warrants investigation of the issue of NMS subtyping within PD.
Authors: Carmen Rodriguez-Blazquez; Anette Schrag; Alexandra Rizos; K Ray Chaudhuri; Pablo Martinez-Martin; Daniel Weintraub Journal: Mov Disord Clin Pract Date: 2020-12-21
Authors: Panteleimon Oikonomou; Daniel J van Wamelen; Daniel Weintraub; Dag Aarsland; Dominic Ffytche; Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Valentina Leta; Corinne Borley; Carolina Sportelli; Dhaval Trivedi; Aleksandra M Podlewska; Katarina Rukavina; Alexandra Rizos; Claudia Lazcano-Ocampo; Kallol Ray Chaudhuri Journal: Brain Behav Date: 2021-03-01 Impact factor: 2.708
Authors: Diane M A Swallow; Michael A Lawton; Katherine A Grosset; Naveed Malek; Callum R Smith; Nin P Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; John Hardy; Huw R Morris; Nigel Williams; Nicholas W Wood; Donald G Grosset Journal: J Parkinsons Dis Date: 2016-03-19 Impact factor: 5.568